review
provid
practic
simpl
logic
approach
diagnosi
manag
patient
acut
infecti
diarrhea
one
common
diagnos
clinic
practic
diarrhea
immunocompromis
host
travel
diarrhea
diarrhea
hospit
patient
also
discuss
episod
acut
diarrhea
selflimit
investig
perform
result
influenc
manag
outcom
adequ
histori
physic
examin
clinician
abl
classifi
acut
diarrheal
ill
assess
sever
determin
whether
investig
need
patient
requir
specif
therapi
therapi
mainli
direct
prevent
dehydr
variou
home
remedi
frequent
suffic
mild
selflimit
diarrhea
howev
largevolum
dehydr
diarrhea
oral
rehydr
solut
use
formul
stimul
sodium
water
absorpt
antidiarrh
agent
use
reduc
number
bowel
movement
diminish
magnitud
fluid
loss
use
agent
opiat
deriv
bismuth
subsalicyl
antibiot
therapi
requir
patient
acut
diarrheal
disord
guidelin
use
present
j
med
iarrhea
defin
product
stool
abnorm
loos
consist
usual
associ
excess
frequenc
defec
excess
stool
output
normal
stool
output
approxim
gday
although
diarrhea
common
symptom
case
selflimit
success
treat
patient
overthecount
medic
acut
diarrhea
defin
diarrhea
present
week
nonspecif
respons
intestin
sever
differ
condit
includ
infect
advers
reaction
drug
inflammatori
bowel
diseas
ischemia
specif
drug
poorli
absorb
sugar
caus
acut
diarrhea
discuss
fine
et
al
although
case
diarrhea
result
infect
tabl
specif
organ
identifi
minor
patient
patient
seek
medic
attent
diarrhea
sever
prolong
develop
worrisom
symptom
fever
prostrat
rectal
bleed
acut
infecti
diarrhea
acquir
predominantli
fecalor
rout
ingest
water
food
contamin
pathogen
microorgan
ingest
microorgan
must
overcom
host
defens
mechan
includ
gastric
acid
low
ph
normal
stomach
bactericid
bacteri
enteropathogen
local
system
immun
mechan
gutassoci
lymphoid
tissu
elabor
immunoglobulin
defensin
cryptdin
provid
cellular
humor
protect
microorgan
gastrointestin
motil
impair
abil
microorgan
adher
mucosa
acut
diarrhea
import
caus
morbid
mortal
pediatr
geriatr
patient
underdevelop
countri
incid
mortal
acut
diarrhea
greatest
children
latin
america
exampl
incid
approxim
diarrheal
episod
per
year
first
year
life
factor
thought
increas
morbid
mortal
develop
countri
review
acut
diarrhea
also
common
problem
unit
state
western
europ
incid
approxim
one
episod
per
person
per
year
comparison
common
caus
acut
infecti
diarrhea
western
world
lessdevelop
countri
shown
tabl
sever
special
situat
includ
hospitalacquir
diarrhea
travel
diarrhea
diarrhea
immunocompromis
host
discuss
separ
mani
condit
caus
acut
chronic
diarrhea
use
classifi
diarrheal
ill
one
two
clinic
syndrom
either
wateri
noninflammatori
diarrheal
syndrom
inflammatori
diarrheal
syndrom
classif
usual
made
clinic
simpl
inexpens
diagnost
test
unit
state
patient
wateri
noninflammatori
diarrhea
ill
selflimit
requir
specif
therapi
evalu
patient
gener
unreward
usual
unnecessari
contrast
mani
patient
acut
inflammatori
diarrhea
specif
pathogen
diagnos
patient
may
benefit
antibiot
therapi
noninflammatori
diarrheal
syndrom
character
wateri
stool
may
larg
volum
l
per
day
without
blood
pu
sever
abdomin
pain
fever
type
diarrhea
caus
bacteria
vibrio
cholera
enterotoxigen
escherichia
coli
staphylococc
clostridi
food
poison
virus
rotaviru
norwalk
agent
protozoa
cryptosporidium
giardia
infect
agent
alter
normal
absorpt
secretori
process
enterocyt
lead
wateri
diarrhea
mani
organ
caus
chang
elabor
enterotoxin
syndrom
morpholog
mucosa
remain
normal
minim
alter
thu
stool
fecal
leukocyt
occult
blood
inflammatori
diarrheal
syndrom
character
frequent
smallvolum
mucoid
bloodi
stool
may
accompani
tenesmu
fever
sever
abdomin
pain
caus
organ
induc
acut
inflammatori
reaction
small
larg
intestin
stool
may
mani
leukocyt
frequent
occult
gross
blood
fecal
polymorphonuclear
leukocyt
posit
stool
lactoferrin
test
indi
adequ
medic
histori
complet
physic
examin
essenti
determin
possibl
diagnos
degre
sever
complic
suggest
investig
tabl
list
specif
histor
clue
diagnosi
acut
diarrhea
state
host
immun
system
consid
patient
infecti
diarrhea
common
caus
impair
host
immun
system
includ
iga
defici
acquir
immunodefici
syndrom
aid
immunosuppress
therapi
organ
transplant
use
corticosteroid
patient
suscept
convent
microorgan
well
unusu
organ
cryptosporidium
microsporidium
isospora
belli
cytomegaloviru
mycobacterium
aviumintracellular
infect
immunocompromis
patient
may
also
sever
like
complic
recalcitr
treatment
travel
diarrhea
affect
million
peopl
year
area
frequent
occurr
mexico
central
south
america
mediterranean
basin
middl
east
southeast
asia
likelihood
acquir
travel
diarrhea
area
travel
diarrhea
caus
sever
pathogen
common
enterotoxigen
e
coli
howev
sever
organ
includ
salmonella
shigella
campylobact
giardia
entamoeba
histolytica
rotaviru
also
caus
syndrom
diarrhea
usual
occur
within
day
arriv
destin
although
may
begin
return
home
basic
principl
diagnosi
describ
previous
although
effect
antibiot
regimen
prophylaxi
travel
diarrhea
recommend
travel
case
selflimit
bismuth
subsalicyl
peptobismol
safe
efficaci
treatment
mild
travel
diarrhea
sever
prolong
case
respond
therapi
quinolon
antibiot
occasion
howev
diarrhea
persist
lead
chronic
diarrheal
syndrom
character
temporari
malabsorpt
ultim
resolv
chronic
malabsorpt
syndrom
similar
tropic
sprue
ill
mimic
irrit
bowel
syndrom
acut
diarrhea
hospit
patient
may
result
infect
clostridium
difficil
ingest
elixir
contain
sorbitol
mannitol
acetaminophen
theophyllin
medic
side
effect
consequ
tube
feed
thu
routin
stool
examin
enter
pathogen
ova
parasit
usual
unreward
costeffect
antibioticassoci
diarrhea
result
c
difficil
infect
common
caus
acut
diarrhea
hospit
patient
diarrhea
rang
mild
ill
lifethreaten
diseas
associ
pseudomembran
coliti
follow
treatment
almost
enter
parenter
antibiot
thu
hospit
patient
develop
diarrhea
especi
patient
treat
cephalosporin
clindamycin
evalu
presenc
c
difficil
toxin
tissu
cultur
cytotox
sensit
specif
result
avail
day
rapid
enzymelink
immunosorb
assay
elisa
test
toxin
b
sensit
specif
result
avail
hour
patient
usual
respond
promptli
treatment
oral
metronidazol
oral
vancomycin
although
approxim
treat
patient
relaps
symptom
usual
within
week
complet
therapi
patient
may
treat
second
cours
metronidazol
vancomycin
therapi
may
chang
anoth
antibiot
oral
bacitracin
rifampin
term
refer
five
type
e
coli
specif
clinic
epidemiolog
featur
enterotoxigen
e
coli
etec
enteropathogen
e
coli
epec
enteroinvas
e
coli
eiec
enteroadher
e
coli
eaec
enterohemorrhag
e
coli
ehec
enterotoxigen
e
coli
produc
diseas
adher
mucosa
product
toxin
may
heat
labil
heat
stabl
distribut
worldwid
account
case
travel
diarrhea
enteropathogen
e
coli
associ
primarili
diarrhea
children
year
old
although
caus
travel
diarrhea
enteroinvas
e
coli
invad
mucosa
produc
dysenterylik
syndrom
similar
shigella
enteroadher
e
coli
poorli
understood
may
caus
persist
diarrhea
children
four
type
diarrheagen
e
coli
rare
diagnos
necessari
laboratori
test
routin
avail
infect
enterohemorrhag
e
coli
character
coliti
bloodi
diarrhea
hemorrhag
coliti
may
complic
hemolyticurem
syndrom
thrombot
thrombocytopen
purpura
although
caus
differ
serotyp
e
coli
elabor
shigalik
toxin
serotyp
common
type
enterohemorrhag
e
coli
infect
endem
epidem
unit
state
transmit
food
commonli
ground
meat
isol
easili
hospit
laboratori
use
sorbitolmacconkey
agar
specif
type
serum
elisa
detect
shigalik
toxin
stool
avail
yet
routin
use
adequ
medic
histori
physic
examin
clinician
abl
classifi
acut
diarrheal
ill
determin
sever
possibl
complic
clinician
also
abl
determin
whether
diagnost
test
need
episod
acut
diarrheal
ill
unit
state
selflimit
diagnost
test
kept
minimum
treatment
aim
prevent
dehydr
investig
focus
toward
diagnosi
specif
pathogen
suggest
histori
appropri
send
entir
array
stool
cultur
stool
examin
everi
patient
perform
result
influenc
manag
outcom
diagnost
test
reserv
patient
sever
ill
larg
volum
dehydr
diarrhea
sever
abdomin
pain
cours
patient
inflammatori
diarrhea
bloodi
stool
system
symptom
fever
prostrat
patient
recent
travel
highrisk
area
immunocompromis
patient
figur
diagnost
test
acut
infecti
diarrhea
normal
host
includ
stool
cultur
bacteri
pathogen
stool
examin
ova
parasit
stool
test
clostridium
difficil
toxin
e
coli
microbiolog
laboratori
stool
sent
cultur
enter
pathogen
process
shigella
salmonella
campylobact
enter
pathogen
yersinia
vibrio
e
coli
routin
sought
therefor
clinic
suspicion
organ
high
microbiolog
depart
need
notifi
medic
histori
suggest
risk
factor
c
difficil
recent
antibiot
exposur
recent
hospit
daycar
exposur
recent
chemotherapi
stool
test
c
difficil
toxin
invas
investig
includ
flexibl
sigmoidoscopi
biopsi
upper
gastrointestin
endoscopi
duoden
aspir
biopsi
reserv
special
situat
immunocompromis
patient
stool
examin
yield
diagnosi
tabl
case
acut
diarrhea
selflimit
specif
therapi
necessari
therapi
direct
prevent
dehydr
restor
fluid
loss
although
often
done
intraven
also
accomplish
oral
fluidelectrolyt
therapi
oral
intak
encourag
minim
risk
dehydr
misconcept
bowel
need
rest
oral
intak
worsen
diarrheal
ill
abandon
import
howev
avoid
milk
lactosecontain
product
viral
bacteri
enteropathogen
often
result
transient
lactas
defici
lead
lactos
malabsorpt
caffeinecontain
product
avoid
caffein
increas
cyclic
amp
level
thu
promot
secret
fluid
worsen
diarrhea
variou
home
remedi
includ
cola
beverag
gatorad
fruit
juic
soft
drink
commonli
use
frequent
suffic
patient
mild
selflimit
diarrhea
howev
patient
dehydr
largevolum
diarrhea
remedi
avoid
fluid
hyperosmolar
defici
electrolyt
thu
poor
replac
diarrheal
loss
rather
glucosecontain
electrolyt
solut
use
glucos
intestin
lumen
facilit
absorpt
sodium
therebi
water
cotransport
mechan
usual
unaffect
infecti
microorgan
toxin
sever
oral
rehydr
solut
develop
take
advantag
glucosesodiumcoupl
transport
mechan
tabl
sever
commerci
avail
strongli
recommend
use
adult
well
children
approach
patient
acut
diarrhea
goal
initi
evalu
distinguish
medic
import
diarrhea
benign
selflimit
diarrhea
focus
four
categori
informationth
sever
ill
durat
diarrhea
set
diarrhea
obtain
state
host
defens
immunityth
clinician
decid
patient
requir
addit
investig
treatment
modifi
pharmacotherapi
antidiarrh
agent
acut
infecti
diarrhea
reduc
number
bowel
movement
diminish
magnitud
fluid
electrolyt
loss
commonli
use
agent
includ
opiat
opiat
deriv
loperamid
diphenoxyl
bismuth
subsalicyl
kaolincontain
agent
major
effect
opiat
deriv
slow
intestin
transit
time
although
also
possess
proabsorpt
antisecretori
effect
intestin
anticholinerg
agent
effect
control
symptom
may
caus
signific
advers
side
effect
therefor
recommend
adsorb
agent
kaopect
attapulgit
stool
textur
modifi
use
frequent
overthecount
medic
efficaci
uncertain
bismuth
subsalicyl
peptobismol
safe
efficaci
treatment
infecti
bacteri
diarrhea
stimul
intestin
sodium
water
reabsorpt
bind
enterotoxin
direct
antibacteri
effect
concern
agent
decreas
intestin
transit
time
contraind
invas
infecti
diarrhea
greatli
overst
use
compound
patient
gener
safe
patient
discomfort
substanti
physician
hesit
recommend
short
cours
agent
antibiot
therapi
requir
acut
diarrheal
disord
patient
mild
diseas
complic
clinic
improv
need
antibiot
therapi
infecti
diarrheal
ill
result
virus
cryptosporidiosi
effect
therapi
howev
treatment
recommend
shigellosi
travel
diarrhea
pseudomembran
enterocol
cholera
sexual
transmit
diseas
parasit
use
antibiot
therapi
organ
yersinia
campylobact
outbreak
enteropathogen
e
coli
less
clear
gener
recommend
tabl
specif
antibiot
dosag
discuss
recent
review
howev
widespread
use
antibiot
mani
isol
c
jejuni
shigella
salmonella
resist
mani
antibiot
thu
choic
antibiot
whenev
possibl
base
antibiot
sensit
pattern
patient
commun
